Insights

Precision Medicines Focus Maze Therapeutics is developing novel precision medicines for renal, cardiovascular, and metabolic diseases, presenting an opportunity to target healthcare providers in these specific therapeutic areas for potential sales partnerships.

Strong Financial Backing With significant funding of $190 million and a revenue range of $10-50 million, Maze Therapeutics has the financial stability to support large-scale collaborations and investment opportunities for pharmaceutical distributors or investors looking to enter the biotechnology sector.

Tech-Driven Approach Utilizing a robust tech stack including tools like Google Cloud and GraphQL, Maze Therapeutics demonstrates a commitment to leveraging technology in drug development. This emphasis on tech could attract tech-savvy partners interested in the biotech space.

Strategic Partnerships Having partnered with industry giants like Sanofi Group, Maze Therapeutics has a track record of strategic collaborations. This signals a willingness to work with established players in the market, making them an attractive potential partner for companies seeking innovative biotech solutions.

Clinical Trial Progress With ongoing clinical trials like the Phase 1 trial for MZE782, Maze Therapeutics is advancing its drug pipeline. This presents a chance for contract research organizations (CROs) or clinical trial service providers to explore collaboration opportunities and contribute to the drug development process.

Maze Therapeutics Tech Stack

Maze Therapeutics uses 8 technology products and services including Cookie Notice, git, NetSuite, and more. Explore Maze Therapeutics's tech stack below.

  • Cookie Notice
    Cookie Compliance
  • git
    Development
  • NetSuite
    E-commerce
  • Google Cloud
    Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Informa
    Miscellaneous
  • GraphQL
    Programming Languages
  • Google Tag Manager
    Tag Management

Media & News

Maze Therapeutics's Email Address Formats

Maze Therapeutics uses at least 1 format(s):
Maze Therapeutics Email FormatsExamplePercentage
FLast@mazetx.comJDoe@mazetx.com
93%
Last@mazetx.comDoe@mazetx.com
5%
FMiddleLast@mazetx.comJMichaelDoe@mazetx.com
2%

Frequently Asked Questions

Where is Maze Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Maze Therapeutics's main headquarters is located at 171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US. The company has employees across 4 continents, including North AmericaEuropeAfrica.

What is Maze Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Maze Therapeutics's official website is mazetx.com and has social profiles on LinkedIn.

How much revenue does Maze Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2024, Maze Therapeutics's annual revenue reached $15M.

What is Maze Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Maze Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Maze Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2024, Maze Therapeutics has approximately 132 employees across 4 continents, including North AmericaEuropeAfrica. Key team members include Chief Executive Officer: J. C.Chief Strategy & Business Officer: A. D.Chief Medical Officer: S. N.. Explore Maze Therapeutics's employee directory with LeadIQ.

What industry does Maze Therapeutics belong to?

Minus sign iconPlus sign icon
Maze Therapeutics operates in the Biotechnology Research industry.

What technology does Maze Therapeutics use?

Minus sign iconPlus sign icon
Maze Therapeutics's tech stack includes Cookie NoticegitNetSuiteGoogle CloudjQueryInformaGraphQLGoogle Tag Manager.

What is Maze Therapeutics's email format?

Minus sign iconPlus sign icon
Maze Therapeutics's email format typically follows the pattern of . Find more Maze Therapeutics email formats with LeadIQ.

How much funding has Maze Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2024, Maze Therapeutics has raised $115M in funding. The last funding round occurred on Dec 03, 2024 for $115M.

When was Maze Therapeutics founded?

Minus sign iconPlus sign icon
Maze Therapeutics was founded in 2018.
Maze Therapeutics

Maze Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics. Advances in these areas have enabled us to decode the mysteries of genetic modifiers in a range of severe diseases, which we aim to turn into medicines that mimic protective mutations. We have assembled a world-class team that we need to realize this vision, including creative scientific pioneers in genetics, experienced company builders, and biotech industry leaders.

Section iconCompany Overview

Headquarters
171 Oyster Point Blvd Suite 300 South San Francisco, California 94080 US
Website
mazetx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
51-200

Section iconFunding & Financials

  • $115M

    Maze Therapeutics has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2024 in the amount of $115M.

  • $10M$50M

    Maze Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $115M

    Maze Therapeutics has raised a total of $115M of funding over 4 rounds. Their latest funding round was raised on Dec 03, 2024 in the amount of $115M.

  • $10M$50M

    Maze Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.